AdJane refuerza la inmunidad de las mucosas para franquicias de vacunas respiratorias

Nm-nOMVPositive

AI Analysis

Summary

AdJane presents a mucosal immunity enhancement strategy for next-generation respiratory vaccine franchises, showcasing its clinically validated Nm-nOMV platform with patented mucosal components through a white paper.

Importance:3/10

Sentiment:

0.50

vaccinerespiratorymucosal immunityplatform technologywhite paper

Read the original article

Published by PR Newswire Clinical Trials on September 10, 2026 7:05 AM

Read Original